148 related articles for article (PubMed ID: 33558069)
1. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
[TBL] [Abstract][Full Text] [Related]
2. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
[TBL] [Abstract][Full Text] [Related]
3. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
7. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
8. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
9. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
11. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
Langenbecks Arch Surg; 2024 Jan; 409(1):45. PubMed ID: 38252293
[TBL] [Abstract][Full Text] [Related]
13. Preoperative controlling nutritional status score predicts systemic disease recurrence in patients with resectable biliary tract cancer.
Mito M; Sakata J; Hirose Y; Abe S; Saito S; Miura Y; Ishikawa H; Miura K; Takizawa K; Ichikawa H; Shimada Y; Kobayashi T; Wakai T
Eur J Surg Oncol; 2023 Feb; 49(2):399-409. PubMed ID: 36404251
[TBL] [Abstract][Full Text] [Related]
14. Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma.
Kang MJ; Choi YS; Jang JY; Han IW; Kim SW
World J Surg; 2013 Feb; 37(2):437-42. PubMed ID: 23188530
[TBL] [Abstract][Full Text] [Related]
15. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.
Si A; Li J; Xing X; Lei Z; Xia Y; Yan Z; Wang K; Shi L; Shen F
Surgery; 2017 Apr; 161(4):897-908. PubMed ID: 27989605
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.
Ohira M; Kobayashi T; Hashimoto M; Tazawa H; Abe T; Oshita A; Kohashi T; Irei T; Oishi K; Ohdan H;
Int J Surg; 2018 Jun; 54(Pt A):156-162. PubMed ID: 29730072
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
[TBL] [Abstract][Full Text] [Related]
19. Patterns of initial disease recurrence after resection of biliary tract cancer.
Jung SJ; Woo SM; Park HK; Lee WJ; Han MA; Han SS; Kim SH; Park SJ; Kim TH; Koh YH; Hong EK
Oncology; 2012; 83(2):83-90. PubMed ID: 22777276
[TBL] [Abstract][Full Text] [Related]
20. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
